Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:IRTC NASDAQ:ISRG NYSE:PATH On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeIRTCiRhythm Technologies$177.37+0.7%$171.30$55.92▼$187.57$5.70B1.15456,189 shs228,524 shsISRGIntuitive Surgical$435.73+1.4%$458.68$425.00▼$616.00$156.20B1.612.07 million shs1.86 million shsPATHUiPath$17.15+0.6%$11.99$9.38▼$18.74$9.11B1.0713.87 million shs39.67 million shs5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceIRTCiRhythm Technologies0.00%+0.34%-2.01%+26.84%+208.74%ISRGIntuitive Surgical0.00%-5.03%-4.47%-16.82%-11.38%PATHUiPath0.00%+32.11%+49.56%+36.66%+34.13%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeIRTCiRhythm Technologies$177.37+0.7%$171.30$55.92▼$187.57$5.70B1.15456,189 shs228,524 shsISRGIntuitive Surgical$435.73+1.4%$458.68$425.00▼$616.00$156.20B1.612.07 million shs1.86 million shsPATHUiPath$17.15+0.6%$11.99$9.38▼$18.74$9.11B1.0713.87 million shs39.67 million shs5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceIRTCiRhythm Technologies0.00%+0.34%-2.01%+26.84%+208.74%ISRGIntuitive Surgical0.00%-5.03%-4.47%-16.82%-11.38%PATHUiPath0.00%+32.11%+49.56%+36.66%+34.13%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceIRTCiRhythm Technologies 2.80Moderate Buy$180.231.61% UpsideISRGIntuitive Surgical 2.59Moderate Buy$584.7634.20% UpsidePATHUiPath 2.06Hold$13.21-22.94% DownsideCurrent Analyst Ratings BreakdownLatest ISRG, IRTC, and PATH Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails10/13/2025ISRGIntuitive SurgicalUBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$529.0010/13/2025IRTCiRhythm TechnologiesBTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$190.00 ➝ $195.0010/13/2025ISRGIntuitive SurgicalBTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$571.00 ➝ $529.0010/10/2025IRTCiRhythm TechnologiesRobert W. BairdSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOutperform$180.00 ➝ $220.0010/8/2025IRTCiRhythm TechnologiesWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)10/8/2025ISRGIntuitive SurgicalWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C+)10/8/2025PATHUiPathWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D)10/7/2025IRTCiRhythm TechnologiesEvercore ISISubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetIn-Line$185.00 ➝ $175.0010/7/2025IRTCiRhythm TechnologiesCitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$183.00 ➝ $205.0010/7/2025ISRGIntuitive SurgicalEvercore ISISubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetIn-Line$535.00 ➝ $450.0010/2/2025PATHUiPathBMO Capital MarketsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetMarket Perform$12.50 ➝ $13.00(Data available from 10/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookIRTCiRhythm Technologies$657.23M8.67N/AN/A$2.90 per share61.16ISRGIntuitive Surgical$9.15B17.08$8.10 per share53.78$46.41 per share9.39PATHUiPath$1.43B6.37$0.03 per share562.08$3.33 per share5.15Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateIRTCiRhythm Technologies-$113.29M-$2.93N/AN/AN/A-14.06%-90.03%-8.52%10/29/2025 (Estimated)ISRGIntuitive Surgical$2.32B$7.1760.7757.114.5128.51%14.56%12.93%10/21/2025 (Estimated)PATHUiPath-$73.69M$0.03571.63N/A6.311.35%1.28%0.83%12/4/2025 (Estimated)Latest ISRG, IRTC, and PATH EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails10/29/2025Q3 2025IRTCiRhythm Technologies-$0.36N/AN/AN/A$184.75 millionN/A10/21/2025Q3 2025ISRGIntuitive Surgical$2.00N/AN/AN/A$2.41 billionN/A9/4/2025Q2 2026PATHUiPath$0.08$0.15+$0.07$0.02$347.36 million$361.73 million7/31/2025Q2 2025IRTCiRhythm Technologies-$0.53-$0.32+$0.21-$0.44$173.94 million$186.69 million7/22/2025Q2 2025ISRGIntuitive Surgical$1.93$2.19+$0.26$1.81$2.35 billion$2.44 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthIRTCiRhythm TechnologiesN/AN/AN/AN/AN/AISRGIntuitive SurgicalN/AN/AN/AN/AN/APATHUiPathN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioIRTCiRhythm Technologies6.255.024.88ISRGIntuitive SurgicalN/A5.174.18PATHUiPathN/A2.752.75Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipIRTCiRhythm TechnologiesN/AISRGIntuitive Surgical83.64%PATHUiPath62.50%Insider OwnershipCompanyInsider OwnershipIRTCiRhythm Technologies1.10%ISRGIntuitive Surgical0.70%PATHUiPath23.19%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableIRTCiRhythm Technologies2,00032.13 million31.91 millionOptionableISRGIntuitive Surgical15,638358.48 million355.97 millionOptionablePATHUiPath3,868531.02 million407.88 millionOptionableISRG, IRTC, and PATH HeadlinesRecent News About These CompaniesStock Price Soars Nearly 50%! The 'Intelligent Agent Automation' Fueled by UiPath, and Yisaiqi Has Found a New PlayOctober 13 at 11:07 AM | sohu.comSUiPath: Hard Not To Be Bullish On Their Agentic AI FutureOctober 13 at 6:01 AM | seekingalpha.comInspire Investing LLC Makes New Investment in UiPath, Inc. $PATHOctober 12 at 4:37 AM | marketbeat.comHow Analyst Perspectives on UiPath Are Shifting With New Partnerships and Product InnovationsOctober 11 at 5:17 AM | finance.yahoo.comUiPath, Inc. (NYSE:PATH) Receives Consensus Rating of "Hold" from BrokeragesOctober 11 at 5:09 AM | marketbeat.comLightning Round: I can't recommend UiPath, had too big of a move, says Jim CramerOctober 10 at 12:16 AM | msn.comDaniel Dines Sells 122,734 Shares of UiPath (NYSE:PATH) StockOctober 10 at 7:42 PM | marketbeat.comInsider Alert: UiPath CEO Offloads Millions in Shares Amid Strong RallyOctober 10 at 7:15 PM | finance.yahoo.comUiPath (PATH) Declines More Than Market: Some Information for InvestorsOctober 10 at 6:46 PM | zacks.comUiPath (NYSE:PATH) Trading Down 8% - Should You Sell?October 10 at 5:40 PM | marketbeat.comUiPath (PATH): Assessing Valuation After Rapid Share Price SurgeOctober 10 at 2:15 PM | finance.yahoo.comWhy UiPath (PATH) Shares Are Falling TodayOctober 10 at 2:15 PM | msn.comUiPath (NYSE:PATH) Sees Large Volume Increase - Should You Buy?October 10 at 12:13 PM | marketbeat.comUiPath Recognized as a Leader in the Gartner® Magic Quadrant™ for AI-Augmented Software Testing ToolsOctober 10 at 9:14 AM | theglobeandmail.comUiPath stock soars to 16-month high amid optimism around AI partnershipsOctober 10 at 9:14 AM | msn.comUiPath Platform™ for Agentic Automation and Orchestration Named One of TIME's Best Inventions of 2025October 10 at 8:00 AM | businesswire.comUiPath (NYSE:PATH) Shares Up 19.1% - Still a Buy?October 9, 2025 | marketbeat.comUiPath (PATH) Hits Fresh High on AI BoostOctober 9, 2025 | insidermonkey.comUiPath (NYSE:PATH) Reaches New 1-Year High - What's Next?October 9, 2025 | marketbeat.comUiPath Recognized as a Leader in the Gartner® Magic Quadrantâ„¢ for AI-Augmented Software Testing ToolsOctober 9, 2025 | businesswire.comUiPath CEO Daniel Dines Sells 122,734 Shares: What It Means for InvestorsOctober 9, 2025 | sohu.comSNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesSoundHound Breaks Critical Resistance: How High Can It Get Now?By Thomas Hughes | September 28, 2025The Fed Cut Rates: What Now for the S&P 500 and Equity Markets?By Thomas Hughes | September 18, 2025ISRG, TEAM, SFM Trade Well Below Highs With 30%+ UpsideBy Leo Miller | September 23, 2025Is Intuitive Surgical the Hidden Winner in Healthcare’s Weakness?By Gabriel Osorio-Mazilli | October 1, 2025The New Brain of Business: UiPath Is Creating an AI RevolutionBy Jeffrey Neal Johnson | October 2, 2025ISRG, IRTC, and PATH Company DescriptionsiRhythm Technologies NASDAQ:IRTC$177.37 +1.17 (+0.66%) Closing price 04:00 PM EasternExtended Trading$177.55 +0.18 (+0.10%) As of 04:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.Intuitive Surgical NASDAQ:ISRG$435.73 +6.14 (+1.43%) Closing price 04:00 PM EasternExtended Trading$436.14 +0.40 (+0.09%) As of 05:23 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.UiPath NYSE:PATH$17.15 +0.10 (+0.58%) Closing price 03:59 PM EasternExtended Trading$17.32 +0.17 (+1.00%) As of 05:23 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.UiPath Inc. provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization. Its platform's embedded AI, ML, and NLP capabilities improve decisioning and information processing; emulate human behavior allows organizations to address a myriad of use cases; emulate human behavior allows organizations to address a myriad of use cases; multi-tenant platform enterprise deployment with security and governance and Automation Cloud, which enables customers to begin automating without the need to provision infrastructure, install applications, or perform additional configurations; intuitive interface and low-code, drag-and-drop functionality; signed to enable people and automations to work together; and tracks, measures, and forecasts the performance of automations, enables customers to gain powerful insights and generate key performance indicators with actionable metric. It serves banking and financial services, healthcare, insurance, public sectors, manufacturing, retail, and telecom industries. The company was founded in 2005 and is headquartered in New York, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas 5 Stocks and ETFs to Weather Volatility as Trade Tensions Rise 2 Reasons Absci Could Be the Future of AI Biotech, and 1 Risk Applied Digital’s Shorts Got Squeezed—Now What? Levi Strauss Stock Set to Reach New Highs in 2026 Alphabet: The AI Powerhouse Driving Markets Into 2026 Is the Reddit-ChatGPT Love Affair Over? Broadcom Gets Second $420 Target as CPO Win Boosts Outlook AST SpaceMobile's Big Win: Shares Soar on New Deal With Verizon Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
